Menu
Recruiting NCT04748770

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Observational Kidney Transplant Access Obese Patients Dialysis Comorbidities

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Kidney Transplant Access, Obese Patients, Dialysis, Comorbidities. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Obesity is in constant increase all over the world and affects 35% of the global population according to the World Health Organisation. It is associated with other cardiovascular risk factors (particularly hypertension and diabetes) and with high morbi-mortality. It is also responsible for an increase of the risk of developing chronic kidney diseases (CKD). In fact, obese patients represent 25% of the dialysis population and Picardy is one of the most affected areas. However, their access to kidney transplant is still restricted and the reasons are not completely understood.

Primary outcome measures

  • variation of pre-transplant status two years after the obese patients' dialysis initiation between both groups [Time frame: two years]

Eligibility criteria

Inclusion criteria

  • Age over 18 years old.
  • Patients with BMI≥30 kg/m2 (for study population) and 25≤BMI≤30 kg/m2(for control population) one month after dialysis initiation.
  • Patients agree with their data collection.

Exclusion criteria

  • Patients with bariatric surgery history.
  • Patients needed dialysis for graft dysfunction.
  • Data loss.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-only

Study locations

France · 1 center
  • CHU Amiens — Amiens

Identifiers

NCT: NCT04748770 · PI2021_843_0016

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗